Stocks with momentum


Momentum stocks have been on the nose of late. The “COVID beneficiaries” like the tech stocks are giving back much of their gains in the rotation to value and cyclical stocks.

Given just how well those stocks did, it is easy to imagine them falling quite a bit further. And it is broader than just FANGMAN, (the full suite of COVID plays) including Zoom, Peloton, DocuSign, to name a few, and also includes the Consumer Discretionary stocks, which benefited from households with lots of savings and nothing to spend it on bar goods.

We think Consumer Discretionary stocks have peaked for the foreseeable future, which has negative implications for our crop of highly performing consumer names like JBH, HVN, NCK and APE.


Some of the momentum trades however, to our mind, were just…difficult to fathom. GameStop (GME) might be the example of the moment, about companies that are trading with a disconnect to fundamentals, but our preferred example remains TLSA.

A core part of our process is parsing (i.e. trying to understand) market narratives, and a very clear market narrative was the belief in the genius of Musk, and the first mover advantage in AV/EV technologies, leading to global dominance.

We thought that reverse engineering a TLSA (by other automakers) would prove easier than scaling up automotive manufacturing (by TLSA).

And the key to deciding which narrative was in effect was the price. As the charts above and below show, the TLSA enterprise value was worth more than all the other named companies combined, by a handsome margin, whilst the sales (and by derivation the capex, R&D spend, and marketing capabilities) were but a fraction.


The danger to momentum (as a factor premium) is that it misses turning points. With TLSA the turning point was the failure to accelerate production.

With AGL, it was the market extrapolation of high wholesale electricity prices, which resulted in an over-earning business, with peak margins and peak sales capitalised into perpetuity.

We’d been watching the price rise with a mix of stunned disbelief, largely because we knew that a number of factors (heatwaves, supply outages, the dislocation from renewables entering the market [which isn’t a negative comment on renewables, but, for the sake of brevity I won’t explore that thread in this note]) had temporarily driven prices higher, and wouldn’t prove sustainable.

In 2017 we had politicians campaigning on public platforms pledging to get prices down. It clearly set up a perfect, potent mix to cause a de-rating, firstly in the P/E multiple, and secondly in the earnings.

The point

So what’s the point?

Often stocks have good momentum, because something favourable is going their way, leading to upgrades, and the market gets behind it.

Often those drivers are temporary, and in the COVID beneficiaries case it was COVID itself (temporary, on the assumption that the virus could and would be defeated).

In TLSA’s case it was the idolatry of the charismatic maverick. Eventually, your heroes outrun their accomplishments.

In AGL’s case it was the weather, the technology, and the politicians.

Where else do we see over-extrapolated earnings expectations?

Well, we see it in the buy-now-pay-later space.

We see it in the commodity stocks (most notably the iron ore names, but steel, as a derivative of the same idea, and for most of the gold names).

And in several others.

But we’ll leave the note here.

Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.

This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.

Please note that past performance is not a reliable indicator of future performance.

General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.

Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.

Receive our investment insights

Something went wrong. Please check your entries and try again.